Intravenous immunoglobulin treatment of children with autism

Journal of Child Neurology

Volumn 13, Issue 2, 1998, Pages 79-82

  Plioplys, Audrius V ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b MERCY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADOLESCENT; ALERTNESS; ARTICLE; AUTISM; AUTOIMMUNITY; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HUMAN; HYPERACTIVITY; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031978921     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389801300207     Document Type: Article

References (17)

1. Coleman M, Gillberg C: The Biology of the Autistic Syndromes. New York, Praeger, 1985.
2. Weizman A, Weizman R, Szekely GA, et al: Abnormal immune response to brain tissue antigen in the syndrome of autism. Am J Psych 1982;139:1462-1465.
3. Stubbs EG, Crawford ML, Burger DL, et al: Depressed lymphocyte responsiveness in autistic children. J Autism Child Schizophr 1977;7:49-55.
4. Warren RP, Margaretten NC, Pace NC, et al: Immune abnormalities in patients with autism. J Autism Dev Disord 1986;16:189-197.
5. Yonk LJ, Warren RP, Burger RA, et al: CD4+ helper T cell depression in autism, Immunol Lett 1990;25:341-345.
6. Warren RP, Yonk LJ, Burger RA, et al. Deficiency of suppressorinducer T cells in autism, Immunol Invest 1990;19:245-251.
7. Warren RP, Margaretten NC, Foster A. Reduced natural killer cell activity in autism. J Am Acad Child Adolesc Psychol 1987;26: 333-335.
8. Todd R, Ciaranello R: Demonstration of inter-and intra-species differences in serotonin binding sites by antibodies from an autistic child. Proc Natl Acad Sci USA 1985;82:612-616.
9. Fudenberg HH, Singh VK, Emerson D, et al: Immunodiagnosis and immunotherapy in autistic children. J Neuroimmunol 1987;16: 58-59.
10. Plioplys AV, Greaves A, Kazemi K, et al: Lymphocyte function in autism and Rett Syndrome. Neuropsychobiol 1994;29:12-16.
11. Plioplys AV, Greaves A, Kazemi K, et al: Immunoglobulin reactivity in autism and Rett Syndrome. Dev Brain Dysfunc 1994;7:12-16.
12. Van Doom PA, Brand A, Strengere PFW, et al: High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: A double blind placebo-controlled cross over study. Neurology 1990;40:209-212.
13. Cosi V, Lombardi M, Piccolo G, et al: Treatment of myasthenia gravis with high dose intravenous immunoglobulin. Acta Neurol Scand 1991;84:81-84.
14. Dalakas MC: Current treatment of inflammatory myopathies. Curr Opin Rheumatol 1994;6:595-601.
15. Gross-Tsur V, Shalev RS, Kazir E, et al: Intravenous high-dose gamma globulins for intractable childhood epilepsy. Acta Neurol Scand 1993;88:204-209.
16. Achiron A, Pras E, Gilad R, et al: Open controlled trial of intravenous immune globulin in relapsing-remitting multiple sclerosis. Arch Neurol 1992;49:1233-1236.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed revised. Washington, DC, American Psychiatric Association, 1987.